These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 29934227)

  • 21. Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.
    Meurice T; Tricot O; Lemesle G; Deneve M; Lejeune P; Biausque F; Cordier C; Savoye C; Hennebert O; Taghipour K; Sivery B; Pruvost P; Alaoui M; Carpentier L; Segrestin B; Lamblin N; Bauters C
    Arch Cardiovasc Dis; 2015; 108(6-7):340-6. PubMed ID: 25858539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH; Roe MT; Chen AY; Lytle BL; Pollack CV; Brindis RG; Smith SC; Harrington RA; Fintel D; Fraulo ES; Califf RM; Gibler WB; Ohman EM; Peterson ED
    Arch Intern Med; 2006 Oct; 166(18):2027-34. PubMed ID: 17030838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.
    Kotseva K; Wood D; De Backer G; De Bacquer D; Pyörälä K; Keil U;
    Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):121-37. PubMed ID: 19287307
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Turkish assessment of SURF (SUrvey of Risk Factor Management) study: Control rates of cardiovascular risk factors derived from databases of 15 different levels of health centers in Turkey.
    Tokgözoğlu L; Oğuz A; Balcı MK; Temizhan A; Güldal Altunoğlu E; Bektaş O; Aslan G; Iyigün Ö; Kara A; Tanrıverdi Pınar H; Yavuz S; Tekin M; Ercan S; Çelik S; Sezgin Meriçliler Ö; Bozkurt Çakır İ
    Turk Kardiyol Dern Ars; 2017 Jul; 45(5):398-407. PubMed ID: 28694393
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suboptimal management of cardiovascular risk factors in coronary heart disease patients in primary care occurs particularly in women.
    Driscoll A; Beauchamp A; Lyubomirsky G; Demos L; McNeil J; Tonkin A
    Intern Med J; 2011 Oct; 41(10):730-6. PubMed ID: 21627740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of lipid abnormalities and cholesterol target value attainment in patients with stable coronary heart disease or an acute coronary syndrome in Saudi Arabia.
    Al Sifri S; Al Shammeri O; Al Jaser S; Alkhenizan A; Bin Shafi Shafiurrehman A; Morcos B; Wajih S; Elnahal I; Horack M; Brudi P; Lautsch D; Ambegaonkar B; Vyas A; Baxter CA; Gitt AK
    Saudi Med J; 2018 Jul; 39(7):697-704. PubMed ID: 29968891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased adherence to cardiac standards of care during participation in cardiac disease management programs.
    Coberley C; Morrow G; McGinnis M; Wells A; Coberley S; Orr P; Shurney D
    Dis Manag; 2008 Apr; 11(2):111-8. PubMed ID: 18426377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effects of inpatient rehabilitation on cardiovascular risk factors in patients with coronary heart disease. PIN-Study Group].
    Völler H; Hahmann H; Gohlke H; Klein G; Rombeck B; Binting S; Willich SN
    Dtsch Med Wochenschr; 1999 Jul; 124(27):817-23. PubMed ID: 10432941
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The second Euro Heart Survey on acute coronary syndromes: Characteristics, treatment, and outcome of patients with ACS in Europe and the Mediterranean Basin in 2004.
    Mandelzweig L; Battler A; Boyko V; Bueno H; Danchin N; Filippatos G; Gitt A; Hasdai D; Hasin Y; Marrugat J; Van de Werf F; Wallentin L; Behar S;
    Eur Heart J; 2006 Oct; 27(19):2285-93. PubMed ID: 16908490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ASPIRE-3-PREVENT: a cross-sectional survey of preventive care after a coronary event across the UK.
    Jennings CS; Kotseva K; Bassett P; Adamska A; Wood D;
    Open Heart; 2020 Apr; 7(1):. PubMed ID: 32354740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea.
    Byeon HJ; Yang YM; Choi EJ
    Ther Clin Risk Manag; 2016; 12():167-75. PubMed ID: 26929629
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between patient's health literacy and adherence to coronary heart disease secondary prevention measures.
    Lu M; Ma J; Lin Y; Zhang X; Shen Y; Xia H
    J Clin Nurs; 2019 Aug; 28(15-16):2833-2843. PubMed ID: 30938879
    [TBL] [Abstract][Full Text] [Related]  

  • 33. API expert consensus document on management of ischemic heart disease.
    Association of Physicians of India
    J Assoc Physicians India; 2006 Jun; 54():469-80. PubMed ID: 16909697
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secondary prevention for acute coronary syndrome in rural South Australia: are drugs best? What about the rest?
    Wachtel TM; Kucia AM; Greenhill JA
    Rural Remote Health; 2008; 8(4):967. PubMed ID: 18855517
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.
    Blomkalns AL; Chen AY; Hochman JS; Peterson ED; Trynosky K; Diercks DB; Brogan GX; Boden WE; Roe MT; Ohman EM; Gibler WB; Newby LK;
    J Am Coll Cardiol; 2005 Mar; 45(6):832-7. PubMed ID: 15766815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-physician health workers for improving adherence to medications and healthy lifestyle following acute coronary syndrome: 24-month follow-up study.
    Sharma KK; Gupta R; Mathur M; Natani V; Lodha S; Roy S; Xavier D
    Indian Heart J; 2016; 68(6):832-840. PubMed ID: 27931556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hospital revascularisation capability and quality of care after an acute coronary syndrome in Switzerland.
    Welker J; Auer R; Gencer B; Muller O; Cornuz J; Matter CM; Mach F; Windecker S; Rodondi N; Nanchen D
    Swiss Med Wkly; 2016; 146():w14275. PubMed ID: 26859223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and sex inequalities in the prescription of evidence-based pharmacological therapy following an acute coronary syndrome in Portugal: the EURHOBOP study.
    Pereira M; Araújo C; Dias P; Lunet N; Subirana I; Marrugat J; Capewell S; Bennett K; Azevedo A
    Eur J Prev Cardiol; 2014 Nov; 21(11):1401-8. PubMed ID: 23787795
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-hospital prescriptions of secondary-prevention medications for post-acute coronary syndrome patients in South Korea
.
    Kang HB; Choi M; Yoon SG; Cho YS; Je NK
    Int J Clin Pharmacol Ther; 2018 Jan; 56(1):1-11. PubMed ID: 29168689
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.